To the full analysis
Buyback calculator for Charles River Laboratories International
Charles River Laboratories International stock: dividend
CRLCharles River Laboratories International does not currently pay a dividend. From fiscal 2023 to 2025, Charles River Laboratories International bought back its own shares for $504M.
Whether Charles River Laboratories International, Inc. pays a dividend and what the company does with its cash instead: free cash flow, buybacks of its own shares and the share count over recent years.
Daily figure as of 13 Nov 2026
Free cash flow and buybacks
| Fiscal year | Free cash flow | Share buybacks | Shares outstanding |
|---|---|---|---|
| 2025 | $518.49M | $360.67M | 49.56M |
| 2024 | $501.61M | $119.18M | 51.38M |
| 2023 | $365.37M | $24.16M | 51.23M |
| 2022 | $294.91M | $38.65M | 50.81M |
| 2021 | $532.03M | $40.71M | 50.29M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 27 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 7 Aug 2026)
- Valuation signal Overvalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.